Unraveling Drug Approvals in Rare Diseases: A Decade in Review
Over the past decade, the Food and Drug Administration (FDA) in the U. S. has faced an uphill task when it comes to approving drugs for rare diseases. These diseases, often with small patient populations, come with unique challenges like varied genetic and symptom patterns. This makes it tough to fi